WHO naming stem · suffix · 53 listed names
-pin(e)
This page was written with AI.
tricyclic compounds
Where it sits in a name
WHO writes the stem as -pin(e). It has 2 spellings or places: pine at the end of the name (…pine); pin at the end of the name (…pin).
Of the 53 names WHO lists under it, 44 carry pine at the end of the name, 9 carry pin at the end of the name.
All 53 names WHO lists under -pin(e)
These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.
Beside each name: the brand names it appears under in the US list (FDA Drugs@FDA) and the EU central list (EMA), or that neither list carries it. 11 of 53 names appear in these lists: 11 in the US list (FDA Drugs@FDA) and 4 in the EU central list (EMA); 14 have national brands in at least one EU/EEA country. Each brand opens in this site's brand lookup. A name is found when the agency's ingredient name is the same name once salt words such as hydrochloride or sodium are set aside (the list of those words); where WHO's own name carries such a word (estradiol valerate), the agency must write the same words. A spelling that differs only by the INN letter rules (ph for f, y for i) is found too and shown. Under each name that one or more EU/EEA countries authorise under a national brand of their own (through that country's agency, so not in the EU central list), a line now gives the number of those countries and their codes, from EMA's Article 57 data, and opens the country lookup at that name. A name with none of these lines may still be sold elsewhere, or in Europe only under its own generic name.
- amezepineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- amoxapineEU (central) brands: none found
- asenapineEU (central) brands: Sycrest
- batelapineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- carbamazepineUS brands: CARBATROL, EPITOL, EQUETRO, TEGRETOL, TEGRETOL-XR, TERIL, CARNEXIV (discontinued in FDA listings)EU (central) brands: none found
- cidoxepinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- clorotepineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- clotiapineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- clozapineEU (central) brands: none found
- damotepineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- darenzepineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- dibenzepinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- dizocilpineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- dosulepinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- doxepinEU (central) brands: none found
- elanzepineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- enprazepineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- erizepineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- eslicarbazepineUS brands: APTIOM
- esmirtazapineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- etazepineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- flumezapineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- fluperlapineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- licarbazepineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- loxapineUS brands: ADASUVE, LOXITANE (discontinued in FDA listings), LOXITANE C (discontinued in FDA listings), LOXITANE IM (discontinued in FDA listings)EU (central) brands: Adasuve
- maroxepinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- metiapineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- metitepineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- metoxepinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mezepineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mirtazapineEU (central) brands: none found
- nuvenzepineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- olanzapinein combination: LYBALVI with samidorphan l-malate; SYMBYAX (discontinued in FDA listings) with fluoxetineEU (central) brands: Olanzapine Glenmark, Olanzapine Glenmark Europe, Olanzapine Teva, Olanzapine Viatris, Olazax, Olazax Disperzi, Zalasta, Zypadhera, Zyprexa, Zyprexa Velotab, Olansek (withdrawn), Olanzapine Apotex (withdrawn), Olanzapine Cipla (withdrawn)
- oxcarbazepineEU (central) brands: none found
- pentiapineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- perlapineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pinoxepinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pirenzepineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- prazepineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- propizepineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- quetiapineEU (central) brands: none found
- rilapineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rispenzepineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- savoxepinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- serazapineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- siltenzepineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- spiroxepinNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- telenzepineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tenilapineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tilozepineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tropatepineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zicronapineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- zolenzepineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
US list: Drugs@FDA, from the FDA Drugs@FDA data (openFDA bulk file), checked . It keeps discontinued brands, marked here as FDA marks them.
EU (central) list: EMA medicines list, European Medicines Agency (EMA), checked . Medicines authorised for the whole EU through EMA only: a brand authorised by one country's own agency is not in it. Source: European Medicines Agency (EMA), medicines list, checked 2026-09-24.
EU/EEA national lists: European Medicines Agency (EMA), Article 57 product data, downloaded (EMA's Article 57 page). Brand names authorised by each country's own agency, as the country lookup reads them; a product named after its substance and maker ("Paracetamol Teva") is not counted as a brand, and EU central authorisations are not counted as a country. GB in a list is Northern Ireland, which EMA's data carries alongside the EU/EEA countries.
Decode another name
Decoded
dosulepin
Listed INNCarries the WHO stem -pin(e)
- -pin(e)end of the nameWHO lists it hereWHO definition: tricyclic compounds
“dosulepin” is an INN that WHO lists under -pin(e) in the 2024 stem book.
The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.
Source and licence
The definition of -pin(e) (Part II B) and the 53 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .
Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.